Fosun International LTD Biomarin Pharmaceutical Inc Transaction History

Fosun International LTD

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 11, 2021	SELL	$74.73 - $90.69 $186,825 - $226,725	-2,500 Closed	0 $0
Q4 2020 Feb 05, 2021	SELL	$72.61 - $90.2 $181,525 - $225,500	-2,500 Reduced 50.0%	2,500 $215,000
Q3 2020 Nov 12, 2020	SELL	$71.87 - $131.03 $431,220 - $786,180	-6,000 Reduced 54.55%	5,000 $380,000
Q2 2020 Aug 12, 2020	BUY	$79.55 - $124.22 $477,300 - $745,320	6,000 Added 120.0%	11,000 $1.34 Million
Q3 2019 Nov 12, 2019	SELL	$67.4 - $85.11 $6.24 Million - $7.89 Million	-92,650 Reduced 94.88%	5,000 $342,000
Q1 2019 May 10, 2019	BUY	$84.2 - $98.62 $648,340 - $759,374	7,700 Added 8.56%	97,650 $8.58 Million
Q4 2018 Jan 31, 2019	BUY	$80.14 - $106.07 $721,260 - $954,629	9,000 Added 11.12%	89,950 $7.56 Million
Q3 2018 Nov 09, 2018	BUY	$93.92 - $105.72 $7.6 Million - $8.56 Million	80,950 New	80,950 $7.93 Million

632

185M

1.63M

1.2M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $13.1B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of Fosun International LTD, based on Form 13F filings with the SEC.

Stay updated on Fosun International LTD with notifications on news.